Literature DB >> 8404098

Augmented resting sympathetic activity in awake patients with obstructive sleep apnea.

J T Carlson1, J Hedner, M Elam, H Ejnell, J Sellgren, B G Wallin.   

Abstract

Muscle nerve sympathetic activity (MSA) was recorded during wakefulness in 11 patients with obstructive sleep apnea (OSA) and in 9 sex- and age-matched healthy control subjects. Plasma levels of norepinephrine (NE) and neuropeptide Y were analyzed. Five patients had established hypertension (resting supine systolic BP/diastolic BP > or = 160/95 mm Hg). The investigation was performed after a minimum of 3 weeks' washout period of antihypertensive medication. Muscle sympathetic activity during supine rest was higher in patients compared with controls (p < 0.01) with no difference between normotensive and hypertensive patients. However, systolic, but not diastolic, BP was positively related to resting MSA (n = 20, p < 0.01). There was no significant correlation between body mass index and MSA. Resting MSA was unrelated to disease severity expressed as apnea frequency or minimum SaO2 during the overnight recording. Both the arterial and venous plasma norepinephrine was higher in patients compared with controls (p < 0.05). Plasma levels of NE correlated to resting MSA (p < 0.01) in the whole study group (patients and controls) but not within the respective subgroups. No significant correlation, however, was found between plasma NE (arterial and venous) and BP. Plasma neuropeptide Y-like immunoreactivity was similar in patients and controls. However, one patient with hypertension had approximately twice this level in repeated samples. It is concluded that neurogenic sympathetic activity as well as circulating plasma NE is increased in patients with OSA. This increased sympathetic activity during awake supine rest may reflect a pathophysiologic adaptation to hypoxia and hemodynamic changes occurring at repetitive apneas during sleep. The correlation between MSA and systolic BP implies that this mechanism may be directly or indirectly involved in the development of cardiovascular complications in OSA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8404098     DOI: 10.1378/chest.103.6.1763

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  149 in total

Review 1.  Prognosis and sleep disordered breathing in heart failure.

Authors:  I Wilcox; S G McNamara; T Wessendorf; G N Willson; A J Piper; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Sleep apnoea in women.

Authors:  N Edwards; I Wilcox; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 4.  Sleep apnoea and snoring: potential links with vascular disease.

Authors:  C E Sullivan; S G McNamara
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

5.  Functional organization of the insula in men and women with obstructive sleep apnea during Valsalva.

Authors:  Amrita Pal; Jennifer A Ogren; Andrea P Aguila; Ravi Aysola; Rajesh Kumar; Luke A Henderson; Ronald M Harper; Paul M Macey
Journal:  Sleep       Date:  2021-01-21       Impact factor: 5.849

6.  CrossTalk opposing view: Most cardiovascular diseases in sleep apnoea are not caused by sympathetic activation.

Authors:  Lena Lavie; Peretz Lavie
Journal:  J Physiol       Date:  2012-06-15       Impact factor: 5.182

7.  Polysomnography underestimates altered cardiac autonomic control in patients with obstructive sleep apnea.

Authors:  C Jilek; J Gebauer; F Muders; M Arzt; G Riegger; M Pfeifer; R Wensel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

Review 8.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 9.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

10.  Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea.

Authors:  Barbara J Morgan; Mihaela Teodorescu; David F Pegelow; Emily R Jackson; Devin L Schneider; David T Plante; James P Gapinski; Scott J Hetzel; John M Dopp
Journal:  Exp Physiol       Date:  2018-06-08       Impact factor: 2.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.